Recipharm AB has appointed Henrik Stenqvist as its new executive vice president and chief financial officer, effective on April 24, 2017. He will be based at the company’s headquarters in Stockholm, Sweden and reports to Thomas Eldered, chief executive officer of Recipharm.

Mr. Stenqvist brings 24 years’ finance and management experience to Recipharm. Prior to joining Recipharm he served as chief financial officer of the Meda Group and held other leading finance positions in the pharmaceutical industry.

“I am very pleased to welcome Henrik, his extensive experience and perspectives in finance, business and strategic development in the pharmaceutical industry make him a great fit for Recipharm as we continue on our strong growth path,” said Mr. Eldered.